We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHY
951
DELISTED
WESTERN ASSET MANAGED HIGH INCOM FD INC. COM
MHY
$49K 0.01%
+10,989
New +$47.6K
KGC icon
952
Kinross Gold
KGC
$28.5B
$48K 0.01%
14,217
-20,960
-60% -$52K
ACHV icon
953
Achieve Life Sciences
ACHV
$632M
$47K 0.01%
31
-22
-42% -$35.8K
DSU icon
954
BlackRock Debt Strategies Fund
DSU
$590M
$46K 0.01%
+4,383
New +$43.5K
CLDX icon
955
Celldex Therapeutics
CLDX
$2.83B
$45K 0.01%
+789
New +$88.8K
TGA
956
DELISTED
Transglobe Energy Corp
TGA
$45K 0.01%
+27,018
New +$39.5K
GLBL
957
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$45K 0.01%
+18,880
New +$65.5K
DARE icon
958
Dare Bioscience
DARE
$19.8M
$43K 0.01%
+132
New +$37.2K
TLPH icon
959
Talphera
TLPH
$65.4M
$41K 0.01%
+665
New +$46.1K
COOP
960
DELISTED
Mr. Cooper
COOP
$40K 0.01%
1,408
-43
-3% -$1.22K
GST
961
DELISTED
Gastar Exploration Inc.
GST
$35K 0.01%
32,023
-112,609
-78% -$116K
ALT icon
962
Altimmune
ALT
$576M
$34K ﹤0.01%
+59
New +$30.2K
PTX
963
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$32K ﹤0.01%
3,061
-87,901
-97% -$1.75M
GAU
964
Galiano Gold
GAU
$481M
$31K ﹤0.01%
+14,711
New +$27K
LEE icon
965
Lee Enterprises
LEE
$171M
$30K ﹤0.01%
+1,683
New +$26.3K
PXLW icon
966
Pixelworks
PXLW
$37.9M
$30K ﹤0.01%
1,128
-2,635
-70% -$63.2K
LINC icon
967
Lincoln Educational Services
LINC
$1.3B
$29K ﹤0.01%
+11,605
New +$29.9K
VSLR
968
DELISTED
VIVINT SOLAR, INC.
VSLR
$29K ﹤0.01%
+10,780
New +$69.4K
MNI
969
DELISTED
The McClatchy Company Class A Common Stock
MNI
$29K ﹤0.01%
2,788
-5,219
-65% -$55.5K
EVRI
970
DELISTED
Everi Holdings
EVRI
$25K ﹤0.01%
+10,974
New +$32.9K
DRRX
971
DELISTED
DURECT Corp
DRRX
$23K ﹤0.01%
1,741
-1,205
-41% -$15.4K
RTK
972
DELISTED
Rentech, Inc.
RTK
$23K ﹤0.01%
10,414
-46,807
-82% -$101K
XOMA
973
DELISTED
Xoma
XOMA
$20K ﹤0.01%
+1,322
New +$23.8K
LITS
974
Lite Strategy Inc
LITS
$33M
$18K ﹤0.01%
717
-3,250
-82% -$81.1K
CASC
975
DELISTED
Cascadian Therapeutics, Inc.
CASC
$17K ﹤0.01%
2,231
-3,356
-60% -$25.8K
37 38
39
40 41

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.